Cargando…
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
We evaluated in this randomised, double-blind clinical trial the efficacy of melatonin as a prophylactic treatment for prevention of SARS-CoV-2 infection among healthcare workers at high risk of SARS-CoV-2 exposure. Healthcare workers fulfilling inclusion criteria were recruited in five hospitals in...
Autores principales: | García-García, Irene, Seco-Meseguer, Enrique, Ruiz-Seco, Pilar, Navarro-Jimenez, Gema, Martínez-Porqueras, Raúl, Espinosa-Díaz, María, Ortega-Albás, Juan José, Sagastagoitia, Iñigo, García-Morales, María Teresa, Jiménez-González, María, Martínez de Soto, Lucía, Bajo-Martínez, Ana Isabel, del Palacio-Tamarit, María, López-García, Raquel, Díaz-García, Lucía, Queiruga-Parada, Javier, Giesen, Christine, Pérez-Villena, Ana, de Castro-Martínez, Marta, González-García, Juan J., Rodriguez-Rubio, Miguel, de la Oliva, Pedro, Arribas, José R., Carcas, Antonio J., Borobia, Alberto M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876218/ https://www.ncbi.nlm.nih.gov/pubmed/35207411 http://dx.doi.org/10.3390/jcm11041139 |
Ejemplares similares
-
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
por: García, Irene García, et al.
Publicado: (2020) -
Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study
por: Borobia, Alberto M, et al.
Publicado: (2021) -
Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
por: Marín-Candón, Alicia, et al.
Publicado: (2023) -
Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation
por: García-García, Irene, et al.
Publicado: (2021) -
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
por: García-García, I., et al.
Publicado: (2021)